Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.

Abstract

Hearing loss is the most frequent long-term complication of pneumococcal meningitis, affecting up to 40% of survivors. Unfortunately, adjuvant therapy with dexamethasone has failed to satisfactorily reduce its incidence. Therefore, we evaluated the use of antioxidants for the adjunctive therapy of meningitis-associated deafness. Eighteen hours after… (More)

Topics

Cite this paper

@article{Klein2003MeningitisassociatedHL, title={Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.}, author={Matthias Klein and Uwe Koedel and Hans-Walter Pfister and Stefan Kastenbauer}, journal={Annals of neurology}, year={2003}, volume={54 4}, pages={451-8} }